CymaBay Therapeutics, Inc.
CBAY · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$105,370 | -$106,001 | -$89,998 | -$50,986 |
| Dep. & Amort. | $681 | $710 | $688 | $632 |
| Deferred Tax | -$2,732 | $0 | $637 | $0 |
| Stock-Based Comp. | $15,230 | $9,517 | $9,996 | $7,324 |
| Change in WC | $5,632 | -$2,339 | $6,351 | -$1,591 |
| Other Non-Cash | $14,028 | $14,033 | $2,895 | -$104 |
| Operating Cash Flow | -$72,531 | -$84,080 | -$69,431 | -$44,725 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$445 | -$148 | -$87 | -$21 |
| Net Acquisitions | -$7,864 | -$874 | $637 | -$104 |
| Inv. Purchases | -$305,674 | -$174,977 | -$78,084 | -$176,300 |
| Inv. Sales/Matur. | $219,550 | $129,140 | $126,760 | $224,278 |
| Other Inv. Act. | $7,864 | $874 | -$637 | $104 |
| Investing Cash Flow | -$86,569 | -$45,985 | $48,589 | $47,957 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $345,772 | $0 | $70,499 | $92 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $345,772 | $24,550 | $118,455 | $92 |
| Financing Cash Flow | $345,772 | $24,550 | $118,455 | $92 |
| Forex Effect | -$428 | $0 | $0 | $0 |
| Net Chg. in Cash | $186,244 | -$105,515 | $97,613 | $3,324 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,291 | $125,806 | $28,193 | $24,869 |
| End Cash | $206,535 | $20,291 | $125,806 | $28,193 |
| Free Cash Flow | -$72,976 | -$84,228 | -$69,518 | -$44,746 |